Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Rubin

Showing results (601-610 of 717) with videos related to

Pageof 72
Sort By:
Learning Health Systems|December 22, 2020
Addressing the Covid-19 pandemic and future public health challenges through global collaboration and a data-driven systems approachFrancisco Ros, Rebecca Kush, Charles Friedman, et al.
Gastro Hep Advances|August 12, 2024
An Innovative Forum for Gastroenterology and Hepatology IssuesVinod K Rustgi, Shanthi Srinivasan, Deborah C Rubin, et al.
Cancer|June 1, 1995
Expression and mutation analysis of the p53 gene in uterine papillary serous carcinomaS A King, A A Adas, V A LiVolsi, et al.
Gynecologic Oncology|October 1, 1993
Biodistribution and intraoperative evaluation of radiolabeled monoclonal antibody MX35 in patients with epithelial ovarian cancerS C Rubin, L Kostakoglu, C Divgi, et al.
Psycho-Oncology|July 17, 2016
Group-based trajectory modeling of fear of disease recurrence among women recently diagnosed with gynecological cancersSharon L Manne, Shannon Myers-Virtue, David Kissane, et al.
Gynecologic Oncology|June 11, 1992
Management of vulvar melanomaE L Trimble, J L Lewis, L L Williams, et al.
Gynecologic Oncology|August 11, 1991
Prognostic factors for recurrence following negative second-look laparotomy in ovarian cancer patients treated with platinum-based chemotherapyS C Rubin, W J Hoskins, P E Saigo, et al.
Gynecologic Oncology|June 11, 1992
Randomized prospective trial of 5 versus 10 cycles of cyclophosphamide, doxorubicin, and cisplatin in advanced ovarian carcinomaT B Hakes, E Chalas, W J Hoskins, et al.
The Journal of Clinical Investigation|May 12, 2010
Epimorphin deletion protects mice from inflammation-induced colon carcinogenesis and alters stem cell niche myofibroblast secretionAnisa Shaker, Elzbieta A Swietlicki, Lihua Wang, et al.
Gynecologic Oncology|September 1, 1989
Influence of secondary cytoreduction at the time of second-look laparotomy on the survival of patients with epithelial ovarian carcinomaW J Hoskins, S C Rubin, E Dulaney, et al.
Pageof 72

Showing results (601-610 of 717) with videos related to

Sort By:
Pageof 72
Learning Health Systems|December 22, 2020
Addressing the Covid-19 pandemic and future public health challenges through global collaboration and a data-driven systems approachFrancisco Ros, Rebecca Kush, Charles Friedman, et al.
Gastro Hep Advances|August 12, 2024
An Innovative Forum for Gastroenterology and Hepatology IssuesVinod K Rustgi, Shanthi Srinivasan, Deborah C Rubin, et al.
Cancer|June 1, 1995
Expression and mutation analysis of the p53 gene in uterine papillary serous carcinomaS A King, A A Adas, V A LiVolsi, et al.
Gynecologic Oncology|October 1, 1993
Biodistribution and intraoperative evaluation of radiolabeled monoclonal antibody MX35 in patients with epithelial ovarian cancerS C Rubin, L Kostakoglu, C Divgi, et al.
Psycho-Oncology|July 17, 2016
Group-based trajectory modeling of fear of disease recurrence among women recently diagnosed with gynecological cancersSharon L Manne, Shannon Myers-Virtue, David Kissane, et al.
Gynecologic Oncology|June 11, 1992
Management of vulvar melanomaE L Trimble, J L Lewis, L L Williams, et al.
Gynecologic Oncology|August 11, 1991
Prognostic factors for recurrence following negative second-look laparotomy in ovarian cancer patients treated with platinum-based chemotherapyS C Rubin, W J Hoskins, P E Saigo, et al.
Gynecologic Oncology|June 11, 1992
Randomized prospective trial of 5 versus 10 cycles of cyclophosphamide, doxorubicin, and cisplatin in advanced ovarian carcinomaT B Hakes, E Chalas, W J Hoskins, et al.
The Journal of Clinical Investigation|May 12, 2010
Epimorphin deletion protects mice from inflammation-induced colon carcinogenesis and alters stem cell niche myofibroblast secretionAnisa Shaker, Elzbieta A Swietlicki, Lihua Wang, et al.
Gynecologic Oncology|September 1, 1989
Influence of secondary cytoreduction at the time of second-look laparotomy on the survival of patients with epithelial ovarian carcinomaW J Hoskins, S C Rubin, E Dulaney, et al.
Pageof 72